Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.
about
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionOpioid-induced central immune signaling: implications for opioid analgesiaThe use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic painHeroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individualsToll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence.Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorderMorphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens.Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeRespiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodiesABCB1 transporter and Toll-like receptor 4 in trabecular meshwork cells.Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2.Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in micePharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.The TLR4-Active Morphine Metabolite Morphine-3-Glucuronide Does Not Elicit Macrophage Classical Activation In Vitro.Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasisInteractions between glia, the immune system and pain processes during early development.Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.A presumed antagonistic LPS identifies distinct functional organization of TLR4 in mouse microglia.Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids.Toll-like receptor 4 contributes to the inhibitory effect of morphine on colonic motility in vitro and in vivo.Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia.Strontium ranelate analgesia in arthritis models is associated to decreased cytokine release and opioid-dependent mechanisms.
P2860
Q26771954-CC71F2D7-6539-4558-ABF3-F258B8F5A200Q27021477-5AA1CA29-0848-40AD-B10F-E18D64B881B4Q28307673-45B152F1-BAF0-46FB-B8D4-F73894B917EAQ28545281-57948658-D803-4CEE-BA09-C103B4FE6DA2Q33604982-16D562BB-C5FE-4313-9D8B-0B5C2F7B2C01Q34265484-7FDB0E07-4CB9-4B44-A86B-AF36AA8D0C85Q34569178-DBD19DD9-ADBB-4133-9B76-6D1C4EE315AEQ34603199-E0107272-135F-4E4B-AA70-4F6901C98AAAQ35058641-C8D3B745-27DD-41EC-A6C0-FE92EA373881Q35169679-AC6D0AFC-CBE0-4EAC-9F23-526FF13E3515Q35176850-7A0D2BC7-427B-4DBD-934C-CAF6CEDD9D88Q35762509-33437D55-2894-45CC-BCF3-5C9E3ABF29BCQ35977809-96BCF5B0-AD24-4927-98D6-2B3FA8B5180AQ36599638-75586CBB-06AC-4AD6-91F6-02A80A098970Q36869897-D35F2172-D484-480C-AFBD-791AB58B482CQ37413252-33891820-4831-4B58-9842-04A2AE00E4E7Q37418689-634FCB5F-5699-4844-9C6B-A2276071F8D1Q38182143-351DC26A-3DD6-4C40-BE74-632E370B7A70Q38218630-AF539A62-100D-4070-94F7-9D2A234E178AQ38542687-6D5E458D-04AA-42E2-81CC-39C6823F0B2DQ38893386-31032926-0CA4-4D83-B486-3391CDEDA4ABQ40226833-1C62A733-B033-47E0-ADBF-6B81180FC400Q41654778-16EEA70D-0880-4086-939A-14E4BEDC3C15Q42070484-918EF485-47B5-42D1-A1FF-0D246DC7E76BQ42363257-213B84AB-51B3-4F1F-B99A-227456BE89A0Q44331247-0A12C71F-901C-4940-911C-F27D1FCCD0B6
P2860
Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacological characterizati ...... s at the toll-like receptor 4.
@en
type
label
Pharmacological characterizati ...... s at the toll-like receptor 4.
@en
prefLabel
Pharmacological characterizati ...... s at the toll-like receptor 4.
@en
P2093
P2860
P921
P356
P1476
Pharmacological characterizati ...... s at the toll-like receptor 4.
@en
P2093
P2860
P304
P356
10.1111/BPH.12028
P407
P577
2013-03-01T00:00:00Z